(USD M) | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LTM Revenue % growth | 94.6 423.9% | 112.4 211.4% | 132.1 128.5% | 148.8 80.2% | 171.0 80.8% | 195.8 74.2% | 228.6 73.1% | 271.9 82.8% | 320.9 87.6% | 373.7 90.9% | 444.4 94.4% | 526.9 93.8% | 616.4 92.1% | 710.7 90.2% | 792.6 78.3% | 872.0 65.5% | 959.4 55.7% | 1,067.1 50.1% | 1,242.0 56.7% | 1,476.5 69.3% |
LTM NOPAT % growth | (60.1) N/A | (40.4) (32.8%) | (24.2) (40.1%) | (15.3) (36.9%) | (57.5) 277.0% | (73.9) 28.6% | (94.6) 27.9% | (111.8) 18.2% | (80.1) (28.4%) | (83.2) 3.8% | (78.7) (5.4%) | (68.7) (12.7%) | (63.3) (7.8%) | (52.4) (17.3%) | (41.7) (20.3%) | (41.2) (1.1%) | 76.1 N/A | 3.7 (95.2%) | 69.1 1,780.0% | 109.9 59.1% |
Discount rate | 5.6% | 5.5% | 5.5% | 5.8% | 6.6% | 6.4% | 6.4% | 6.4% | 7.2% | 7.9% | 8.6% | 8.7% | 8.4% | 8.7% | 9.4% | 8.7% | 9.1% | 9.2% | 8.6% | 9.4% |
Earnings Power Value (EPV) | (1,078.2) | (730.8) | (435.9) | (262.3) | (869.2) | (1,159.9) | (1,470.1) | (1,745.2) | (1,112.6) | (1,047.3) | (913.7) | (786.7) | (752.6) | (600.9) | (441.9) | (471.6) | 840.4 | 39.9 | 802.3 | 1,167.3 |
Enterprise Value (EV) | 283.8 | 300.0 | 324.7 | 1,075.1 | 1,831.7 | 1,728.4 | 1,189.0 | 1,032.3 | 836.6 | 746.9 | 958.5 | 1,130.3 | 1,878.4 | 1,715.1 | 1,135.5 | 1,677.2 | 3,092.4 | 4,141.4 | 3,635.1 | 5,211.3 |
Market-Implied Value of Growth (MIVoG) | 1,362.0 | 1,030.8 | 760.7 | 1,337.4 | 2,700.9 | 2,888.3 | 2,659.0 | 2,777.5 | 1,949.2 | 1,794.2 | 1,872.2 | 1,917.0 | 2,631.0 | 2,315.9 | 1,577.5 | 2,148.8 | 2,251.9 | 4,101.5 | 2,832.8 | 4,044.1 |
EPV as % of EV | (379.9%) | (243.6%) | (134.2%) | (24.4%) | (47.5%) | (67.1%) | (123.6%) | (169.1%) | (133.0%) | (140.2%) | (95.3%) | (69.6%) | (40.1%) | (35.0%) | (38.9%) | (28.1%) | 27.2% | 1.0% | 22.1% | 22.4% |
MIVoG as % of EV | 479.9% | 343.6% | 234.2% | 124.4% | 147.5% | 167.1% | 223.6% | 269.1% | 233.0% | 240.2% | 195.3% | 169.6% | 140.1% | 135.0% | 138.9% | 128.1% | 72.8% | 99.0% | 77.9% | 77.6% |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of Dec 31, 2024, Hims & Hers Health, Inc.'s Earnings Power Value is approximately $1,167.3M.
As of Dec 31, 2024, Hims & Hers Health, Inc.'s Enterprise Value (EV) estimates at $5,211.3M.
As of Dec 31, 2024, Hims & Hers Health, Inc.'s Net operating profit after tax (NOPAT) is approximately $109.9M.